Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation? Christos G. Mihos, DO, Orlando Santana,

Intraoperative bypass graft flow in intra-aortic balloon pump–supported patients: Differences in arterial and venous sequential conduits Francesco Onorati,

Successful surgical treatment of chronic ischemic mitral regurgitation achieves left ventricular reverse remodeling but does not affect right ventricular.

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: Up to 21 years of clinical and echocardiographic results

Cardiac surgery–associated neutrophil gelatinase–associated lipocalin score for postoperative acute kidney injury: What is the clinical implication?

POINT: Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation:

Pulmonary hypertension in valve disease: A beast of the past?

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

William M. DeCampli, MD, PhD

A new approach: Ischemic mitral regurgitation guidelines by and for surgeons Patrick M. McCarthy, MD The Journal of Thoracic and Cardiovascular Surgery

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

It is still mostly about the mitral valve

Philippe Menasché, MD, PhD

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent? Giuseppe Santarpino, MD, Steffen.

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

The lord of the rings Antonio Miceli, MD, PhD

The variability of the mitral valve anatomy and terminology

Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines Javier G. Castillo, MD, Anelechi.

Percutaneous edge-to-edge repair in high-risk and elderly patients with degenerative mitral regurgitation: Midterm outcomes in a single-center experience

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Military surgeons just want to have fun

A first start for lung transplantation?

Acute hemodynamic effects of restrictive mitral annuloplasty in patients with end-stage heart failure: Analysis by pressure-volume relations Sven A.F.

Stephen R. Broderick, MD, MPHS

Dynamic RING + STRING for ischemic mitral regurgitation: Papillary muscle repositioning and modification of the septal–lateral diameter in the loaded.

Mechanical heart valves: are two leaflets better than one?

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Is commissural closure associated with mitral annuloplasty a durable technique for the treatment of mitral regurgitation? A long-term (≤15 years) clinical.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Niv Ad, MD, Lawrence M. Wei, MD

Replicating the success of mitral valve repair in the aortic valve

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Commentary: Three-dimensional P3 tethering angle at the heart of future surgical decision making in ischemic mitral regurgitation Wobbe Bouma, MD, PhD,

Warfarin or aspirin after mitral valve repair: Why work harder?

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival Simon Maltais,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Severe tricuspid or mitral regurgitation in inoperable patients with aortic stenosis. Can we leave them alone? Juan A. Crestanello, MD The Journal of.

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

The continuing challenge of congenital heart disease in China

Giuseppe D'Ancona, MD, PhD, Hüseyin Ince, MD, PhD

Prognosis of patients undergoing emergency surgery for type A acute aortic dissection without exclusion of the intimal tear Satoshi Unosawa, MD, PhD,

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Did you like Terminator 3 better than Terminator 2

A good chimney requires a good sweep

Surgery for secondary tricuspid regurgitation: Rings, bands, or sutures, does it matter? Manuel J. Antunes, MD The Journal of Thoracic and Cardiovascular.

The papillary muscle sling for ischemic mitral regurgitation

Journal changes and initiatives

Presentation transcript:

Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy Francesco Onorati, MD, Antonino S. Rubino, MD, Domenico Marturano, MD, Eugenia Pasceri, MD, Giuseppe Santarpino, MD, Stefania Zinzi, MD, Giuseppina Mascaro, MD, Attilio Renzulli, MD, PhD, FECTS The Journal of Thoracic and Cardiovascular Surgery Volume 138, Issue 3, Pages 654-662 (September 2009) DOI: 10.1016/j.jtcvs.2009.01.020 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival (A) and freedom from congestive heart failure (B), redo mitral surgery (C), re-revascularization (D). The Journal of Thoracic and Cardiovascular Surgery 2009 138, 654-662DOI: (10.1016/j.jtcvs.2009.01.020) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Survival (A), freedom from congestive heart failure (B), and mitral reintervention (C) between patients with ischemic chronic mitral regurgitation recurrence and those without ischemic chronic mitral regurgitation recurrence. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 654-662DOI: (10.1016/j.jtcvs.2009.01.020) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Survival (A) and freedom from congestive heart failure (B) between patients with coaptation depth ≥ 0.5 cm at discharge and those with coaptation depth < 0.5 cm at discharge. The Journal of Thoracic and Cardiovascular Surgery 2009 138, 654-662DOI: (10.1016/j.jtcvs.2009.01.020) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions